Search research articles
Contact Us
Filters
Showing results (1101-1110 of 1,133) with videos related to
Page
of 114
Sort By:
Cell Reports. Medicine
|
January 14, 2022
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer
Dongqing Huang, Shrabanti Chowdhury, Hong Wang, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
December 8, 2025
Paediatric pulmonary arterial hypertension following congenital heart defect repair: Enhanced risk stratification and outcomes in a national cohort
Andrew Constantine, Konstantinos Dimopoulos, Robin Condliffe, et al.
Cancer Research
|
February 19, 2021
GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma
Zhiwei Dong, Kok Siong Yeo, Gonzalo Lopez, et al.
Cancer Research
|
July 29, 2021
Acquired <i>RAD51C</i> Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma
Ksenija Nesic, Olga Kondrashova, Rachel M Hurley, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2023
Blueprinting expandable nanomaterials with standardized protein building blocks
Timothy F Huddy, Yang Hsia, Ryan D Kibler, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 4, 2023
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer
Robert W Holloway, Premal Thaker, Alberto A Mendivil, et al.
Cancer Research
|
October 7, 2022
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
Gwo Yaw Ho, Elizabeth L Kyran, Justin Bedo, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
September 21, 2020
Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex
G Trifan, F D Goldenberg, F Z Caprio, et al.
European Heart Journal
|
August 30, 2025
AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome
Saranda Nimani, Sahej Bains, Nicolò Alerni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2025
Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026)
Brian M Slomovitz, S John Weroha, Wei Deng, et al.
Page
of 114
Search research articles
Search
Showing results (1101-1110 of 1,133) with videos related to
Sort By:
Page
of 114
Cell Reports. Medicine
|
January 14, 2022
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer
Dongqing Huang, Shrabanti Chowdhury, Hong Wang, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
December 8, 2025
Paediatric pulmonary arterial hypertension following congenital heart defect repair: Enhanced risk stratification and outcomes in a national cohort
Andrew Constantine, Konstantinos Dimopoulos, Robin Condliffe, et al.
Cancer Research
|
February 19, 2021
GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma
Zhiwei Dong, Kok Siong Yeo, Gonzalo Lopez, et al.
Cancer Research
|
July 29, 2021
Acquired <i>RAD51C</i> Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma
Ksenija Nesic, Olga Kondrashova, Rachel M Hurley, et al.
Biorxiv : the Preprint Server for Biology
|
June 19, 2023
Blueprinting expandable nanomaterials with standardized protein building blocks
Timothy F Huddy, Yang Hsia, Ryan D Kibler, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 4, 2023
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer
Robert W Holloway, Premal Thaker, Alberto A Mendivil, et al.
Cancer Research
|
October 7, 2022
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
Gwo Yaw Ho, Elizabeth L Kyran, Justin Bedo, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
September 21, 2020
Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex
G Trifan, F D Goldenberg, F Z Caprio, et al.
European Heart Journal
|
August 30, 2025
AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome
Saranda Nimani, Sahej Bains, Nicolò Alerni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2025
Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026)
Brian M Slomovitz, S John Weroha, Wei Deng, et al.
Page
of 114